7.25
Schlusskurs vom Vortag:
$6.91
Offen:
$6.91
24-Stunden-Volumen:
293.17K
Relative Volume:
2.18
Marktkapitalisierung:
$362.24M
Einnahmen:
$15.33M
Nettoeinkommen (Verlust:
$-40.19M
KGV:
-4.1377
EPS:
-1.7522
Netto-Cashflow:
-
1W Leistung:
+12.75%
1M Leistung:
+81.25%
6M Leistung:
+29.93%
1J Leistung:
+88.31%
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Firmenname
Trisalus Life Sciences Inc
Sektor
Branche
Telefon
415 336 8917
Adresse
6272 WEST 91ST AVENUE, WESTMINSTER
Vergleichen Sie TLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TLSI
Trisalus Life Sciences Inc
|
7.25 | 345.25M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Eingeleitet | ROTH MKM | Buy |
| 2024-10-25 | Eingeleitet | Northland Capital | Outperform |
| 2024-09-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-30 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
TriSalus Life Sciences Inc Equity Warrant Stock Analysis and ForecastPrice Support Zones & Superior Wealth Building - earlytimes.in
Is TriSalus Life Sciences Inc. Equity Warrant stock vulnerable to regulatory risksJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
How TriSalus Life Sciences Inc. stock valuations compare to rivalsWeekly Risk Summary & AI Enhanced Trading Signals - Newser
TriSalus Life Sciences (Nasdaq: TLSI) plans Dec. 15 KOL event on TriNav PED-TAE - Stock Titan
How TriSalus Life Sciences Inc. stock reacts to job market dataPortfolio Value Report & Intraday High Probability Setup Alerts - Newser
Market Overview: Is Rush Enterprises Inc stock ready for breakoutJuly 2025 Trends & Growth Focused Stock Pick Reports - BỘ NỘI VỤ
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will TriSalus Life Sciences Inc. Equity Warrant stock gain from lower inflationTrade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for growth ETFsJuly 2025 Short Interest & Technical Entry and Exit Tips - Newser
Can TriSalus Life Sciences Stock Hold Up When Markets Turn? - Trefis
Bond Watch: What valuation multiples suggest for TriSalus Life Sciences Inc. stockMarket Performance Recap & High Accuracy Trade Alerts - BỘ NỘI VỤ
TriSalus Life Sciences (NASDAQ:TLSI) Upgraded by Wall Street Zen to Hold Rating - Defense World
What drives TriSalus Life Sciences Inc Equity Warrant stock priceLarge Cap Stability Picks & Options Trading Analysis Tools - earlytimes.in
This trade activity should not be overlooked: TriSalus Life Sciences Inc (TLSI) - Setenews
TriSalus Life Sciences (NASDAQ:TLSIW) Trading Up 2.5% – Here’s Why - Defense World
TriSalus Life Sciences Hits New 52-Week High at $5.95 - Markets Mojo
TLSI Surges As Trinav XP Launch And Q4 PERIO Results Put Investors On Alert - RTTNews
TriSalus (TLSI) Q3 2025 Earnings Call Transcript - AOL.com
Why TriSalus Life Sciences Inc. Equity Warrant stock appeals to analystsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Why hedge funds are buying TriSalus Life Sciences Inc. Equity Warrant stockGap Up & Safe Swing Trade Setups - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Research Analysts Offer Predictions for TLSI FY2026 Earnings - Defense World
Can TriSalus Life Sciences Inc. Equity Warrant stock beat analyst upgradesJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Combining price and volume data for TriSalus Life Sciences Inc.Index Update & Weekly Breakout Stock Alerts - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Is TriSalus Life Sciences Inc. stock a dividend growth opportunity2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
How strong is TriSalus Life Sciences Inc. Equity Warrant stock revenue growthWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
TriSalus Life Sciences Inc. Equity Warrant stock volume spike explainedEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for long term wealth buildingJuly 2025 Retail & Verified Short-Term Plans - newser.com
Is now a turning point for TriSalus Life Sciences Inc. Equity WarrantVolume Spike & Daily Market Momentum Tracking - newser.com
What machine learning models say about TriSalus Life Sciences Inc.July 2025 Levels & Low Risk Entry Point Guides - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity WarrantOil Prices & Capital Efficient Trading Techniques - newser.com
TriSalus Life Sciences Launches TriNav®? XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery?? - marketscreener.com
Finanzdaten der Trisalus Life Sciences Inc-Aktie (TLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):